US Edition
Study: Cannabidiol (CBD) Inhibits Osteosarcoma Growth by Disrupting TNF-α/NF-κB/CCL5 Signaling Pathway
Summary by The Marijuana Herald
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Study: Cannabidiol (CBD) Inhibits Osteosarcoma Growth by Disrupting TNF-α/NF-κB/CCL5 Signaling Pathway
The Marijuana Herald - Marijuana news and information A study published in the journal Phytomedicine “provides the first evidence that CBD inhibits osteosarcoma [a highly aggressive bone cancer] progression by targeting the TNF-α/NF-κB/CCL5 axis, disrupting a coordinated inflammatory-proliferative cascade.” The study, conducted by scientists from multiple departments at Harbin Medical University, including the State Key Laboratory of Frigid Zone…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
